2019 Genitourinary Cancers Symposium

Abstract 228, "Results of a 50 patient single-centre phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer," presented by Dr. Michael Hofman, right, and John Viloet, left, during Poster Session A

San Francisco, CA - 2019 Genitourinary Cancers Symposium – Abstract 228, "Results of a 50 patient single-centre phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer," presented by Dr. Michael Hofman, right, and John Viloet, left, during Poster Session A Photo by © ASCO/Todd Buchanan 2019